Recombinant Mouse Urokinase-type plasminogen activator(Plau)

中文名稱：

Recombinant Mouse Urokinase-type plasminogen activator(Plau)
貨號：

CSB-MP018121MO
說明書：

MSDS Datasheet
規格：

￥708
圖片：
(Tris-Glycine gel) Discontinuous SDS-PAGE (reduced) with 5% enrichment gel and 15% separation gel.
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

純度：

Greater than 95% as determined by SDS-PAGE.
生物活性：

Not Test
基因名：

Plau
Uniprot No.：

P06869
種屬：

Mus musculus (Mouse)
蛋白長度：

Full Length of Mature Protein
來源：

Mammalian cell
分子量：

47.4 kDa
表達區域：

21-433aa
氨基酸序列

GSVLGAPDESNCGCQNGGVCVSYKYFSRIRRCSCPRKFQGEHCEIDASKTCYHGNGDSYRGKANTDTKGRPCLAWNAPAVLQKPYNAHRPDAISLGLGKHNYCRNPDNQKRPWCYVQIGLRQFVQECMVHDCSLSKKPSSSVDQQGFQCGQKALRPRFKIVGGEFTEVENQPWFAAIYQKNKGGSPPSFKCGGSLISPCWVASAAHCFIQLPKKENYVVYLGQSKESSYNPGEMKFEVEQLILHEYYREDSLAYHNDIALLKIRTSTGQCAQPSRSIQTICLPPRFTDAPFGSDCEITGFGKESESDYLYPKNLKMSVVKLVSHEQCMQPHYYGSEINYKMLCAADPEWKTDSCKGDSGGPLICNIEGRPTLSGIVSWGRGCAEKNKPGVYTRVSHFLDWIQSHIGEEKGLAF
Note: The complete sequence may include tag sequence, target protein sequence, linker sequence and extra sequence that is translated with the protein sequence for the purpose(s) of secretion, stability, solubility, etc.
If the exact amino acid sequence of this recombinant protein is critical to your application, please explicitly request the full and complete sequence of this protein before ordering.
蛋白標簽：

C-terminal 10xHis-tagged
產品提供形式：

Liquid or Lyophilized powder Warning: in_array() expects parameter 2 to be array, null given in /www/web/cusabio_cn/public_html/caches/caches_template/default/content/show_product_protein.php on line 662
Note: We will preferentially ship the format that we have in stock, however, if you have any special requirement for the format, please remark your requirement when placing the order, we will prepare according to your demand.
緩沖液：

If the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, pH 8.0.
復溶：

We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Please reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL.We recommend to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20℃/-80℃. Our default final concentration of glycerol is 50%. Customers could use it as reference.
儲存條件：

Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
保質期：

The shelf life is related to many factors, storage state, buffer ingredients, storage temperature and the stability of the protein itself.
Generally, the shelf life of liquid form is 6 months at -20°C/-80°C. The shelf life of lyophilized form is 12 months at -20°C/-80°C.
貨期：

Basically, we can dispatch the products out in 3-7 working days after receiving your orders. Delivery time may differ from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
注意事項：

Repeated freezing and thawing is not recommended. Store working aliquots at 4℃ for up to one week.
Datasheet & COA：

Please contact us to get it.

產品評價

靶點詳情

功能：

Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin.
基因功能參考文獻：
1. downregulation of uPA could decrease the fertility of male mice, which may be caused by a reduction in sperm motility. PMID: 28298247
2. data presented here reveal important information about dynamics in uPA by demonstrating how various ligands can modulate uPA activity by mediating long-range conformational changes PMID: 29420634
3. Lymphangioleiomyomatosis is fatal lung disease associated with germline/somatic inactivating mutations in TSC2 genes. Data suggest lung lymphangioleiomyomatosis lesions and renal angiomyolipomas overexpress uPA; Tsc2-/- (or Tsc1-/-) embryonic fibroblasts from knockout mice express higher uPA levels than wild-type cells. (uPA = urokinase-type plasminogen activator; Tsc = tuberous sclerosis complex protein) PMID: 28972182
4. The findings suggest that the absence of uPA correlates with increased levels of Runx transcriptional regulators in a way that promotes inflammation-associated carcinogenesis. PMID: 29107070
5. an intricate link between caveolin-1 and Src kinase-mediated cell signaling and alveolar epithelial cell apoptosis due to loss of SP-C expression through p53 and uPA system-mediated cross-talk, is reported. PMID: 28385810
6. These studies identify uPA-dependent de-repression of vegfr1 and vegfr2 gene transcription through binding to HHEX/PRH as a novel mechanism by which uPA mediates the pro-angiogenic effects of VEGF and identifies a potential new target for control of pathologic angiogenesis. PMID: 27151212
7. Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models. PMID: 26846181
8. GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model. PMID: 25753270
9. Plau deficiency does not worsen controlled cortical impact-induced brain pathology or epileptogenesis caused by TBI. PMID: 26253597
10. we have firstly shown a fundamental mechanism of urokinase system(uPa and uPAR)-dependent regulation of the trajectory of growth and branching of blood vessels in early embryogenesis and in adults during the repair/regeneration of tissues. PMID: 26863767
11. Pharmacological inhibition of either uPA or selected MMPs decreased atherosclerosis in transgenic uPA mice. PMID: 25616415
12. Porphyromonas gingivalis-derived RgpA-Kgp complex activates the macrophage uPA. PMID: 25979345
13. transgenic alphaMUPA mice, with genetically extended life span, showed a much slower age-related decline in the rate of wound healing than their wild-type counterparts PMID: 25960543
14. Binding of urokinase to urokinase plasminogen activator receptor promotes dendritic spine recovery and functional outcome after ischemic stroke. PMID: 25339736
15. our results suggest a role for uPA and uPAR in experimental autoimmune encephalomyelitis pathogenesis PMID: 24120085
16. Urokinase plasminogen activator is a central regulator of macrophage three-dimensional invasion, matrix degradation, and adhesion. PMID: 24616477
17. SERPINE2 and PLAU are involved in cumulus expansion and oocyte maturation. PMID: 24023701
18. Data suggest urokinase-type plasminogen activator (uPA) is involved in susceptibility/resistance to Group A streptococcal infection (GAS); mice expressing human plasminogen transgene are more susceptible to invasive GAS than uPA knockout mice. PMID: 23853591
19. Mice deficient in urokinase-type plasminogen activator have delayed healing of tympanic membrane perforations. PMID: 23236466
20. PLAU is particularly important for memory Tregs and PLAU mediates Treg suppressor function via STAT5 and ERK signaling pathways. PMID: 23169000
21. The data showed that myeloid-derived suppressor cell accumulation is tumor burden-dependent, and that tumor-derived factors such as plasminogen activator urokinase and its receptor play a role in their recruitment. PMID: 23060546
22. The study establishes the 37- and 70-loops as a unique site for binding to compounds stabilizing the active state of serine proteases. PMID: 22950516
23. Over-expression of uPA plays a synergistic role in the development of liver injury, inflammation and regeneration during acute HBV infection PMID: 22563169
24. Data presented here suggest that MMP-9 is secreted as a multiprotein complex by T. gondii infected macrophages, similar to that observed in metastatic cells. PMID: 22177333
25. u-PA and plasminogen are essential for the phagocytosis of cellular debris by macrophages during liver repair PMID: 22318286
26. Expression of ALDH1A2, BEX2, EGR2, CCL3 and PLAU are upregulated in Toxoplasma gondiisusceptible C57BL/6 mice. PMID: 22451728
27. suggest that uPA promotes cell migration by binding to fibulin-5, initiating its cleavage by plasmin, which leads to its dissociation from beta1-integrin and thereby unblocks the capacity of integrin to facilitate cell motility PMID: 22280367
28. The uPA-uPAR axis has no effect on the formation of Ang II-induced abdominal aortic aneurysms, but uPA deficiency promotes aneurysmal rupture. PMID: 21868698
29. Urokinase type plasminogen activator, at concentrations found under pathological conditions, reduced pulmonary arterial contractility and increased permeability though the activation of NMDA-R1. PMID: 21617202
30. uPA acts in a cell signaling manner via binding to its receptor uPAR rather than as a protease. PMID: 21573723
31. contributes to heterogeneity of macrophages at the border of damaged site during liver repair PMID: 21301782
32. mechanisms of uPA/uPAR/plasminogen-accelerated atherosclerosis and aneurysm formation PMID: 21536666
33. The interaction of sM6P/IGF2R with Plg may be an important regulatory mechanism to inhibit migration of cells using the uPA/uPAR system. PMID: 21273553
34. We propose that u-PA has a protective role in arthritis models with 'wound healing-like' processes following local trauma PMID: 20973954
35. Early experimental venous thrombus resolution is independent of uPA. PMID: 20886179
36. study investigated whether host uPA is a crucial protagonist for the TIMP-1-induced modulation of a pro-metastatic microenvironment in the liver PMID: 19863693
37. uPA/uPAR downregulation suppresses angiogenesis in endothelial cells induced by glioblastoma cell lines PMID: 20805979
38. Selective abrogation of the uPA-uPAR interaction is associated with suppression of fibrin-associated inflammation. PMID: 20466854
39. u-PA is required for the full development of systemic arthritis models involving immune complex formation and deposition. PMID: 20196869
40. uPA plays a critical role in BV-2 microglial cell migration by activating pro-MMP-9, in part by its direct action on MMP-9 and also in part by the activation of plasminogen/plasmin cascade. PMID: 20177776
41. uPA deficiency can unfavorably modulate both delayed neurodegeneration and neurogenesis but has little effect on post-injury neuronal migration and vascular density. Elevated uPA during the post-injury phase is neuroprotective. PMID: 20026272
42. MAPK pathways ERK, JNK/SAPK, and P38-MAPK represent a significant component in the regulation of u-PA expression in human prostate cancer. PMID: 11676474
43. During infection with Cryptococcus neoformans, mice genetically deficient in uPA have a decreased number of recruited effector T cells in the lung, fail to generate a protective T1 profile of cytokines, and display impaired antifungal activity. PMID: 11777975
44. u-PA-/- mice developed significantly milder disease compared with the relevant wild-type mice PMID: 11891190
45. fibrinolysis by uPA-dependent plasmin activity plays a fundamental role in skeletal muscle regeneration PMID: 11929773
46. that u-PA plays important roles in liver regeneration after hepatectomy through control of a transcription factor, c-jun expression. PMID: 11983447
47. the role of urokinase in the regulation of monocyte/macrophage functions, such as that occurring in inflammatory reactions PMID: 12183060
48. uPA regulated by heregulin in mouse neoplasms PMID: 12209601
49. inducible expression reduces fibrosis and mortality after lung injury in mice PMID: 12376355
50. These results suggest that increasing uPA expression by an appropriate combination of growth factors and ECM components constitutes a possible approach to improving the migration of myogenic cells after transplantation. PMID: 12413883
顯示更多

收起更多
亞細胞定位：

Secreted.
蛋白家族：

Peptidase S1 family
數據庫鏈接：

KEGG: mmu:18792

STRING: 10090.ENSMUSP00000022368

UniGene: Mm.4183